Evidence map›Paper›PMID 41409588›Full record

ReviewBioImpacts : BI2025

Gold nanoparticle based fluorescent aptasensors: A chemical and biological detection perspective.

Zahra Hashemi, Tayebeh Hashemi, Azam Samadi, Elaheh Rahimpour

Abstract readReview
In one paragraph

Review in BioImpacts : BI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zahra HashemiDepartment of Biology, Faculty of Engineering and Natural Sciences, Süleyman Demirel University, Isparta, Turkey.ORCID https://orcid.org/0009-0000-9034-2239
Tayebeh HashemiDepartment of Biology, Faculty of Engineering and Natural Sciences, Süleyman Demirel University, Isparta, Turkey.
Azam SamadiPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Elaheh RahimpourPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID https://orcid.org/0000-0002-4037-9436

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In recent decades, the development of simple and reliable techniques for detecting chemical and biological molecules has gained considerable importance. These methods have found extensive applications in different fields, including medicine, biotechnology, food safety, and environmental monitoring. Among these, aptasensors have attracted significant attention owing to their exceptional selectivity, high sensitivity, and versatility in targeting a wide range of analytes. Integrating aptasensors with nanotechnology, particularly gold nanoparticles (Au NPs), has revolutionized the efficiency and performance of these devices. Au NPs, with their unique features like as high surface-to-volume ratio, chemical stability, and extraordinary optical properties, serve as powerful tools for enhancing the aptasensor's capabilities. These features enable signal amplification, reduction of nonspecific interference, and enhancement of accuracy and sensitivity. Methods: This review focuses on recent advances in fluorescent aptasensors amplified by Au NPs. It analyzes the various experiments undertaken to develop and apply these sensors and concludes with a discussion of the technology's future prospects. Results: The findings establish the capability of aptamer-Au NP hybrids to detect a broad spectrum of analytes-including mycotoxins, antibiotics, pesticides, heavy metals, and disease biomarkers-with exceptional sensitivity. Conclusion: This review emphasizes the powerful potential of aptamer-Au NP hybrids for biosensing applications and suggests a path for future work to move this technology from the lab into practical use.

Indexed as

Biological detectionBiosensorChemical detectionFluorescent aptasensorsGold nanoparticle

Identifiers

PMID41409588
PMCPMC12705285

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.